BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14999737)

  • 21. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-state characterization of chlordiazepoxide polymorphs.
    Singh D; Marshall PV; Shields L; York P
    J Pharm Sci; 1998 May; 87(5):655-62. PubMed ID: 9572919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and compaction behaviour of nimesulide crystal forms.
    Di Martino P; Censi R; Barthélémy C; Gobetto R; Joiris E; Masic A; Odou P; Martelli S
    Int J Pharm; 2007 Sep; 342(1-2):137-44. PubMed ID: 17583450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal forms of piroxicam pivalate: preparation and characterization of two polymorphs.
    Giordano F; Gazzaniga A; Moyano JR; Ventura P; Zanol M; Peveri T; Carima L
    J Pharm Sci; 1998 Mar; 87(3):333-7. PubMed ID: 9523987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some physicochemical properties of mefenamic acid.
    Adam A; Schrimpl L; Schmidt PC
    Drug Dev Ind Pharm; 2000 May; 26(5):477-87. PubMed ID: 10789059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
    Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
    J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
    Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A
    J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and crystal characterization of a polymorph, a monohydrate, and an ethyl acetate solvate of the antifungal fluconazole.
    Caira MR; Alkhamis KA; Obaidat RM
    J Pharm Sci; 2004 Mar; 93(3):601-11. PubMed ID: 14762899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphic properties and dissolution profile of efavirenz due to solvents recrystallization.
    Wardhana YW; Soewandhi SN; Wikarsa S; Suendo V
    Pak J Pharm Sci; 2019 May; 32(3):981-986. PubMed ID: 31278710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the crystal forms of pefloxacin: preparation, characterization, and dissolution profile.
    Yadav MR; Shaikh AR; Ganesan V; Giridhar R; Chadha R
    J Pharm Sci; 2008 Jul; 97(7):2637-48. PubMed ID: 17854073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc.
    Zhu H; Padden BE; Munson EJ; Grant DJ
    J Pharm Sci; 1997 Apr; 86(4):418-29. PubMed ID: 9109042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural characteristics and crystal polymorphism of three local anaesthetic bases crystal polymorphism of local anaesthetic drugs: part VII.
    Schmidt AC
    Int J Pharm; 2005 Jul; 298(1):186-97. PubMed ID: 15955643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of submicron-sized niflumic acid crystals prepared by electrospray crystallization.
    Ambrus R; Radacsi N; Szunyogh T; van der Heijden AE; Ter Horst JH; Szabó-Révész P
    J Pharm Biomed Anal; 2013 Mar; 76():1-7. PubMed ID: 23287488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal modification of phenytoin using different solvents and crystallization conditions.
    Nokhodchi A; Bolourtchian N; Dinarvand R
    Int J Pharm; 2003 Jan; 250(1):85-97. PubMed ID: 12480275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.